Screen-printed carbon electrodes were modified with gold nanoparticles bound with DNA-aptamers by two different methods. Aptamers can selectively bind protein tumor markers from the blood plasma. The electrodes were tested. Signals obtained via squire-wavy voltammetry from modified electrodes covered with blood plasma of the healthy donors and donors with lung cancer can be distinguished